Shiraz Ladiwala
Fortune : 869 516 $ au 31/05/2026
Fortune : 869 516 $ au 31/05/2026
Shiraz S.
Ladiwala is currently Lead Independent Director at Mesa Laboratories, Inc. since 2022.
Former positions include Non-Executive Director at Patheon NV and Senior VP-Business Transformation Projects at Thermo Fisher Scientific, Inc. from 2020 to 2021.
Education includes an MBA from the University of Michigan and Stephen M.
Ross School of Business, and an undergraduate degree from the University of Mumbai.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MESA LABORATORIES, INC. 0,15 % | 10/03/2026 | 8 523 ( 0,15 % ) | 869 516 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MESA LABORATORIES, INC. | Directeur/Membre du Conseil | 28/10/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | 31/03/2021 |
| PATHEON N.V. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Mesa Laboratories, Inc.
Mesa Laboratories, Inc. Medical SpecialtiesHealth Technology Manufactures computer-based electronic measurement instruments | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Patheon NV
Patheon NV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development and manufacturing services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national